Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × olaparib × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Other solid neoplasm 3 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 4 Thymoma 1 Pheochromocytoma 1 Paraganglioma 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 Carcinoid Tumor 1 Adrenal Gland Neoplasms 1

Interventions

pembrolizumab 1 olaparib 1 fludarabine phosphate 1 fludarabine 1 PM 01183 1 Nivolumab 1 Irinotecan 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04375267 2023-11-14

LuPARP

Vastra Gotaland Region

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡